Pathology is an integral part of health service delivery, it touches 95% of clinical care pathways.
There is a growing supply-demand dynamic in global pathology services.
A crunch point is developing due to increasing test volumes, increasing test complexity and flat to declining pathologist numbers.
The use of digital pathology (workload balancing) and artificial intelligence (process acceleration) will be a critical part of the solution for shortfalls in pathology services.
Deciphex plans to be at the forefront of this revolution, networking Pathologists from all corners of the globe to drive high-quality, efficient reporting, all while addressing the pathology productivity gap with digital pathology and AI.
Ergonomic workflows integrated with artificial intelligence to optimise pathologist productivity is key in delivery of Deciphex solutions.
Deciphex places the emphasis on triaging out of high volume, low complexity samples, allowing pathologists the time needed to focus on difficult, more challenging content.
Deciphex are focussed on integrating the highest quality proprietary annotated data sets for deep learning development and validation.
Deciphex targets Human Gastrointestinal and Toxicologic Pathology use cases rather than attempting a one size fits all approach.
Diagnexia is an online clinical pathology department that provides on-demand access to remote subspecialty pathologists for primary diagnostics and secondary consult services, supporting the acceleration of diagnostic turnaround times and delivery of the highest quality of patient care.
Donal is an experienced corporate officer in the technology and diagnostics sectors, having 20 years of business leadership experience from start-up through to large corporate enterprise. Donal has considerable M&A experience. He has founded three companies and has senior management experience in Slidepath, Genetix, Leica Microsystems and Leica Biosystems.
Runjan is an experienced Anatomical Pathologist/Histopathologist specialising in GI and pancreatic pathology, who has held chairs of Pathology in South Africa & Glasgow. He was the Program Medical Director & Chief/Professor of Pathology at UHN & University of Toronto. He also was Head of Translational Pathology at the University of Oxford.
Mairin (PhD, MBA) is an experienced COO with >15 years experience in startups and academia. She has considerable experience in operational management, research funding, research programme management and generating IP portfolios. As COO, she also manages all company day to day activities, including defining business strategy, financial, HR and IP.
John has over 25 years Sales, Marketing and CEO experience in technology start-ups & publicly listed technology companies. He has in depth experience in commercialising research, identifying product/market fit & negotiating global licenses. John manages strategic relationships and go to market plans for Deciphex. John is passionate about helping clients simplify & transform the patient experience with AI & advanced service delivery models.
Andrea is an expert software consultant having 10+ years of experience covering a wide range of technical roles, using different technologies and paradigms. Andrea has delivered cutting-edge cloud solutions in a range of fields such as GIS, Healthcare and Finance. Andrea has worked as senior software architect in companies such as Slidepath, Leica Biosystems and Mastercard.
Shane is an experienced, results-oriented manager with over 10+ years of experience in Digital Pathology. Shane has worked in regulated multinationals since 2008 and has held multiple management and leadership roles since 2014. Shane believes all problems can ultimately be solved through constant improvement.
Mirko is an experienced software architect with 10+ years of engineering practice in fields like aerospace & defence, mobile gaming, wearables and AR solutions. Mirko's focus is on software product and engineering practice, quality and innovation. He has contributed significantly to Digital Pathology imaging solutions working in SlidePath and Leica Biosystems.
Colin has almost 20 years of experience focused on the delivery of innovative digital pathology software & services to Academic, Research and Clinical markets. He has worked in both Start-Up and Large Corporate environments, fulfilling a broad remit of customer-facing roles in Business Development, Sales, Commercial Marketing and Strategic Product Management.
Luke has over 15 years of experience in clinical, pharmaceutical and life science with both startups and Fortune 500 corporations. Primarily focused on Digital Pathology and analytics, Luke has led international teams in sales, business development, and marketing. He has a proven track record of exceeding sales goals, novel product launch and expanding market-share in international markets.
Join us for our webinar on Wednesday, July 27th, on the topic “Using Patholytix AI to Identify Signs of Drug Toxicity in Preclinical Safety Assessment Studies”.Read more
This week we were thrilled to get the opportunity to present our poster on the topic “Using AI Based Nuclear Segmentation to Infer Toxicologic Pathology Outcomes such as Liver Hypertrophy from Cell Density Maps”.Read more
Deciphex have announced today that they are first in industry to offer clients Good Laboratory Practice (GLP) compliant digital primary review.Read more
Investment will fuel Deciphex’s role in using AI to accelerate pathology diagnostics, improving productivity and patient outcomes.Read more
Deciphex is participating in the French Society of Toxicological Pathology (SFPT) Congress 2022 in Toulouse, from the 19th - 20th of May.Read more
Deciphex have announced today that it is now a full service provider in Pathology AI and Quantitative Pathology.Read more
Deciphex announce that it has appointed Dr. Trevor McKee as Director of Commercial AI Services for Research Pathology to spearhead this exciting initiative.Read more
Deciphex is exhibiting at the Society of Toxicology (SOT) 61st Annual Meeting and ToxExpo happening in San Diego, California, from the 27-31st of March.Read more
Deciphex have introduced a new service to facilitate on-demand sharing of studies with any veterinary consultant pathologist on a pay-per-use basis with zero cost to the consultant.Read more
Our Director of Commercial AI Services for Research Pathology, Trevor Mc Kee will be speaking at the Digital Pathology & AI Conference 2022 happening virtually, from the 24-25th of March.Read more
Diagnexia is exhibiting at the Institute of Biomedical Science (IBMS) Congress 2022 in Birmingham, from the 14th - 17th of March.Read more
Deciphex is exhibiting at Arab Health 2022 in Dubai, one of the world's leading healthcare and health technologies events.Read more
Diagnexia, a new generation of technology-enabled care provider, powered by Deciphex’s core technologies, announces that they have secured CQC (Care Quality Commission) certification.Read more
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin
1012 95th Street, Naperville,
Exeter Science Park Centre,
6 Babbage Way, Exeter